Trusted Resources
Apr 21, 2013
BACKGROUND:
Cardiac amyloidosis is a fatal disease whose prognosis and treatment rely on identification of the amyloid type. In our aging population transthyretin…
Sep 19, 2010
Introduction:
Cerebral amyloidoma is an infrequently recognized condition that can be confused with a more malignant etiology. Few cases have been reported. We…
Aug 30, 2010
Amyloidomas are benign tumorlike lesions consisting of localized deposits of amyloid and are the rarest form in the group of amyloidosis-related lesions. Diagnosis…
Feb 07, 2001
Sequence Mutations of Human Transthyretin
(reported through 8/2/2001)
Cardiac Amyloidosis: Recognizing Red Flags and Navigating the Diagnostic Workup
In part two of a discussion of data presented at ESC Heart Failure 2026, Apoorva Gangavelli, MD (Emory School of Medicine, CardioNerds Academy House Chief) and…
In this discussion, Apoorva Gangavelli, MD (Emory School of Medicine, CardioNerds Academy House Chief), and Daniel Judge, MD (Medical University of South Carolina…
OverviewHereditary transthyretin-mediated amyloidosis (hATTR) is often under-recognized and misdiagnosed, which can lead to delayed treatment and poor patient…
In an interview with Pharmacy Times during the 2026 Cardiology Day of Education, Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS (AQ-Cardiology), CACP, a…